Reference
Kogo M, et al. Transformation to large cell neuroendocrine carcinoma as acquired resistance mechanism of EGFR tyrosine kinase inhibitor. Lung Cancer 90: 364-368, No. 2, Nov 2015. Available from: URL: http://doi.org/10.1016/j.lungcan.2015.09.002 - Japan
Rights and permissions
About this article
Cite this article
Erlotinib/gefitinib. Reactions Weekly 1589, 100 (2016). https://doi.org/10.1007/s40278-016-14953-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-016-14953-3